Scientists report that their unique HIV vaccine formulation was effective in eliciting strong and balanced immune responses in healthy human volunteers. In light of these initial findings, additional assays on volunteers’ samples were done by other researchers, independently confirming the presence of long lasting and high quality T cell responses against HIV antigens.